Administrative UpdatesTexas A&M spin-off, Pulmotect, Inc., receives $3 million NIH grant to fund infection prevention drug trials
Administrative UpdatesCenter for Epigenetics and Disease Prevention receives Texas A&M Board of Regents stamp of approval
Texas A&M Institute of Biosciences and Technology joins Gulf Coast Consortia, further propels team science across Texas Medical Center